Searchable abstracts of presentations at key conferences in endocrinology

ea0038cmw4.6 | Workshop 4: How do I do it? (II) (Supported by <emphasis role="italic">Clinical Endocrinology</emphasis> and <emphasis role="italic">Endocrinology, Diabetes &amp; Metabolism Case Reports</emphasis>) | SFEBES2015

How do I manage men who have used anabolic steroids?

Toogood Andrew

Anabolic agents are used to enhance performance through their effects on muscle mass, strength, and stamina. The prevalence of anabolic steroid use is difficult to quantify amongst the general population, but estimates derived from anonymous questionnaire studies in various populations suggest use may be common. Up to 4% of 18 years old American males have reported use at least once. Reported use of these agents rises significantly amongst army recruits and further still in el...

ea0028cmw1.2 | The late consequences of cancer therapy in adults | SFEBES2012

The impact of cancer treatment on pituitary function

Toogood Andrew

Improvements in cancer therapy have led to increasing numbers of patients surviving complex conditions. A multidisciplinary approach using new treatment modalities allow more aggressive therapy and a greater risk in the long-term to pituitary function. Damage to the hypothalamic pituitary axis has traditionally resulted from the underlying lesion, surgical intervention and radiotherapy. Traditional chemotherapeutic agents have not been implicated. The effect radiation has upon...

ea0019s57 | Endocrine consequences of cancer treatment | SFEBES2009

Survivorship and models of care for endocrinologists

Toogood AA

Overall survival following childhood cancer is 70% and for some conditions in excess of 90%. This success has come at a cost; 60–70% of patients have one or more on-going medical problem. The most frequent conditions encountered are endocrine in nature, ranging from hypothyroidism to panhypopituitarism. In addition, the prevalence of other medical problems is also increased including heart failure and second malignancy. Consequently this cohort of patients require life-lo...

ea0026p144 | Male reproduction | ECE2011

Does local testosterone therapy in adult men measure up to the 2006 Endocrine Society’s Guidelines?

Hughes D , Toogood A

Introduction: The 2006 Endocrine Society – testosterone therapy in adult men guidelines were audited against the clinical practice at a UK teaching hospital endocrine department. The aim of the audit was to determine whether patients were undergoing appropriate screening tests for prostate cancer and polycythaemia as described in these guidelines.Method: Patients were initially identified by searching the endocrine clinic letter database for the nam...

ea0025p210 | Nursing practise | SFEBES2011

Care of cancer survivors: the role of endocrinologists

Greenfield Diana , Toogood Andrew

Background: Increasing numbers of children and adults are surviving cancer and living with the consequences of their disease or its treatment. The commonest long term consequences observed following childhood cancer are endocrine and there is a growing body of evidence indicating that adults treated for malignant disease are also at risk of endocrine dysfunction.Aim: To determine the involvement of Endocrinologists in the management of cancer survivors a...

ea0044ep61 | (1) | SFEBES2016

A rare case of Follicular Stimulating Hormone (FSH) secreting pituitary adenoma in male

Kempegowda Punith , Ayuk John , Toogood Andrew

A 61-year-old man presented to his primary care service with complains of frequent hot flushes, dizziness and headache. Following initial screening, an incidental pituitary lesion was diagnosed on computed tomography (CT) scan and hence was referred to specialist review. Further detailed history revealed similar presentation with dizziness and hot flushes two and a half years ago. He was then diagnosed with essential hypertension after a negative work-up for Cushing disease. H...

ea0070aep553 | General Endocrinology | ECE2020

‘I would say this is a good clinic for friends & family to be looked after in if they need similar treatment or care’ – Young Adult Endocrine (YAE) Service Evaluation

Feliciano Chona , Gleeson Helena , Toogood Andrew

Aim: To evaluate the current service provisions and provide action plan for improvement within the YAE service.Methods: A friends and family questionnaire given to all patients attending the YAE service from October 2018 – January 2019. Survey questions included: whether they thought this was a good clinic for friends and family to be looked after in, what we did well and what we could do better. For YA patients transferring from children’s s...

ea0011p616 | Neuroendocrinology and behaviour | ECE2006

Rate of change in size of macroprolactinomas with dopamine agonist therapy – is there any relationship to fall in prolactin concentrations?

Miller CL , Palalau A , Toogood AA , Gittoes NJL

The most effective means of treating macroprolactinomas, including those associated with significant visual loss at presentation, is with dopamine agonist (DA) therapy. Improvement in visual function often occurs within days of commencing DA therapy, and usually precedes significant reductions in prolactin (PRL) concentrations and may predate significant evidence of tumour volume reduction by months or years. The temporal association between PRL concentration reductions and tu...

ea0008p67 | Neuroendocrinology and behaviour | SFE2004

PITUITARY FUNCTION IN ADULTS TREATED FOR ACUTE LYMPHOBLASTIC LEUKAEMIA (ALL) DURING CHILDHOOD

McGregor EJ , Jenkinson H , Griffiths A , Toogood AA

Acute lymphoblastic leukaemia is the commonest malignancy to occur during childhood. Treatment protocols included prophylactic cranial radiotherapy at doses of 18-24Gy. Radiation to the hypothalamic-pituitary axis causes hypopituitarism, the severity of which depends upon the dose and time from treatment. Adults who received 24Gy up to 25 years ago have been shown to be GH deficient, those who received 18Gy were not. Other pituitary function was reported be normal. The purpose...

ea0050ep074 | Neuroendocrinology and Pituitary | SFEBES2017

Recurrent lymphocytic hypophysitis during two pregnancies: a very rare case

Chandan Joht Singh , Gittoes Neil , Toogood Andrew , Karavitaki Niki

Lymphocytic hypophysitis (LyH) is a rare condition often associated with pregnancy (usually presenting in the last month of pregnancy or in the first two post-partum months). We describe a very rare case of recurrent LyH during two pregnancies.A 25-years old woman presented in 7/2003 with a 6-week history of headaches and a 2-week history of visual deterioration whilst 38 weeks pregnant. Bitemporal hemianopia was co...